SCHEMBL20176713

SCHEMBL20176713

c1ccc2cc3c(cc2c1)oc1ccc(-c2ccc(-c4c5ccccc5c(-c5ccc(-c6cccc7ccccc67)cc5)c5ccccc45)nc2)cc13

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.38
ENPP3 O14638 1/20 0.38
CCNT1 O60563 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK9 P50750 1/20 0.37
CA12 O43570 3/20 0.35
CA9 Q16790 3/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
ALDH1A1 P00352 5/20 0.34
HSD17B10 Q99714 4/20 0.34
MAPT P10636 4/20 0.34
KMT2A Q03164 3/20 0.34
HPGD P15428 3/20 0.34
MEN1 O00255 2/20 0.34
KDM4E B2RXH2 4/20 0.33
PIM1 P11309 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176453 0.93 CCNT1 (0.39) ENPP1ENPP3CCNT1CCNA2CDK2
SCHEMBL20176636 0.90 ESR1 (0.40) CDK2ALDH1A1HSD17B10MAPTKMT2A
SCHEMBL26160909 0.89 ESR1 (0.40) CDK2ALDH1A1HSD17B10MAPTKMT2A
SCHEMBL26161172 0.89 ESR1 (0.40) CDK2ALDH1A1HSD17B10MAPTKMT2A
SCHEMBL20176705 0.89 ESR1 (0.40) CDK2ALDH1A1HSD17B10MAPTKMT2A
SCHEMBL16067593 0.88 CA12 (0.43) ENPP1ENPP3CA12CA9CA1
SCHEMBL20176460 0.88 MAPK1 (0.35) ALDH1A1HSD17B10MAPTKMT2AHPGD
SCHEMBL20176803 0.87 CYP11B1 (0.37) MAPTCYP1A2CYP2C19RAB9AESR1
SCHEMBL16067647 0.87 ENPP3 (0.39) ENPP1ENPP3CA12CA9CA1
SCHEMBL26161377 0.86 ESR1 (0.38) CDK2ALDH1A1HSD17B10MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 ENPP1 824/4885ENPP3 1028/4885CCNT1 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.